Last reviewed · How we verify

NCT05092555

Clinical Presentations and Outcomes of Patients With Covid-19 Pneumonia

Status unknown Last updated 2 November 2021
What this trial tests

trial testing Nasopharyngeal swap for Reverse transcription polymerase chain reaction in COVID-19 Pneumonia in 200 participants. Status unknown.

Timeline
1 November 2021
Primary endpoint
1 June 2022
1 July 2022

Quick facts

Lead sponsorSohag University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment200
Start date1 November 2021
Primary completion1 June 2022
Estimated completion1 July 2022

Drugs / interventions tested

Conditions studied

Sponsor

Sohag University

Who can join

18 and older, any sex, with COVID-19 Pneumonia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims at determining clinical presentations and outcomes of patients with covid-19 pneumonia and also follow up of patients for up to 6 months to detect possibility of post covid fibrosis

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for COVID-19 Pneumonia

Currently open trials in the same condition.

Other Sohag University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05092555.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing